Pharmacoeconomic Analysis of Axitinib as Second-Line Treatment for Metastatic Renal Cell Carcinoma.

Value Health

Moscow pharmaceutical society, Moscow, Russia.

Published: November 2014

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2014.08.2299DOI Listing

Publication Analysis

Top Keywords

pharmacoeconomic analysis
4
analysis axitinib
4
axitinib second-line
4
second-line treatment
4
treatment metastatic
4
metastatic renal
4
renal cell
4
cell carcinoma
4
pharmacoeconomic
1
axitinib
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!